title: Staying on target with continuous dialysis.
authors.affiliation: Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio; and.
authors.forename: Sevag
authors.initials: S
authors.lastname: Demirjian
authors.affiliation: Department of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee.
authors.forename: William H
authors.initials: WH
authors.lastname: Fissell
mesh_terms: D019794:2,3-Diphosphoglycerate / Q000097:blood*; D058186:Acute Kidney Injury / Q000628:therapy*; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology*; D008297:Male; D017582:Renal Replacement Therapy / Q000009:adverse effects* / Q000379:methods*
chemical_list: D019794:2,3-Diphosphoglycerate
keywords: acute renal failure; dialysis; pharmacokinetics; phosphate uptake